CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Seoul, Seoul-teukbyeolsi [seoul], South Korea and 59 other locations
The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/dose/Vial) administered as a booster in healthy adults aged 19 years old a...
Phase 3
Seoul, Korea, Republic of and 16 other locations
legal age for adult in each country) with confirmed mild or moderate COVID-19 tested positive with a real time reverse transcriptio...
Phase 2, Phase 3
Seoul, Korea, Republic of and 2 other locations
Parallel-treatment Group, Adaptive Design, Multi-center, Phase 2b/3 Trial to Evaluate Efficacy and Safety of NuSepin® Intravenous Infusion in COVID...
Phase 2, Phase 3
Incheon, Namdong-gu, Korea, Republic of
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Seoul, Gyeonggi-do, Korea, Republic of and 66 other locations
The purpose of the study is to evaluate the immunogenicity, reactogenicity, and safety of mRNA-1083 in adults 50 years of age and older in participat...
Phase 3
Seoul, South Korea and 44 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Seoul, Seoul-teukbyeolsi [seoul], South Korea and 201 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Seoul, South Korea and 200 other locations
This study is to evaluate the safety, reactogenicity, and immunogenicity of the QTP104 vaccine against SARS-CoV-2 infection in healthy adults.
Phase 1
Seoul, Korea, Republic of and 1 other location
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Seoul, South Korea and 446 other locations
Clinical trials
Research sites
Resources
Legal